Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 May;52(5):350–354. doi: 10.1136/jcp.52.5.350

Immunohistochemical expression of pi class glutathione S-transferase in the basal cell layer of benign prostate tissue following chronic treatment with finasteride.

R Montironi 1, R Mazzucchelli 1, R Pomante 1, D Thompson 1, V Duval da Silva 1, L Vaught 1, P H Bartels 1
PMCID: PMC1023070  PMID: 10560354

Abstract

BACKGROUND: Glutathione S-transferases (GST) may prevent carcinogenesis through inactivation of reactive electrophiles by conjugation to reduced glutathione. Treatment directed at the induction or preservation of GST-pi expression in normal epithelium could have a profound impact on the prevention of prostate neoplasia. Finasteride, a 5-alpha-reductase inhibitor, is used as a chemopreventive agent because it blocks the conversion of testosterone to its byproduct which promotes prostate tumour growth. OBJECTIVE: To investigate GST-pi expression immunohistochemically in benign prostate tissue from untreated patients and from patients chronically treated with finasteride. MATERIALS: Immunostaining with anti-GST-pi antibody was performed on 10 (cysto-) prostatectomy, eight simple prostatectomy, and three transurethral prostatectomy specimens. The first set of 10 prostates was from untreated patients operated on for bladder cancer. The other cases were from patients with benign prostatic hyperplasia and chronically treated with finasteride. None of the specimens in either group showed prostatic cancer, prostatic intraepithelial neoplasia, urothelial carcinoma, or chronic prostatitis. Specimens were evaluated for the presence, intensity, and distribution of immunostaining. RESULTS: Diffuse cytoplasmic immunostaining was observed in the basal cell layer of the untreated specimens. Some variability in the expression of GST-pi was seen within each zone and also between the prostate zones. Only a minority of the secretory cells was stained weakly, mainly in the subnuclear region of the cells facing an uninterrupted basal cell layer. Staining was more homogeneously diffuse in the cytoplasm of the luminal cells facing the basement membrane directly. In the benign epithelium of the finasteride treated specimens the circumferential staining of the basal cells appeared to be more continuous than in the untreated cases, the gaps in the stained basal cell layer being fewer, shorter, or even absent in some ducts and acini. There was no variability in the intensity of staining of the basal cell layer, all the cells being intensely stained in a uniform way. The intensity of staining of the secretory cells was not influenced by finasteride treatment. CONCLUSIONS: Following chronic treatment with finasteride the immunohistochemical expression of pi class glutathione S-transferase in the benign prostate ducts and acini is upregulated in relation to an expanded basal cell layer. This could indicate that finasteride acts as a GST-pi inducer.

Full text

PDF
350

Images in this article

352Image
on p.352

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker A. M., Oberley L. W., Cohen M. B. Expression of antioxidant enzymes in human prostatic adenocarcinoma. Prostate. 1997 Sep 1;32(4):229–233. doi: 10.1002/(sici)1097-0045(19970901)32:4<229::aid-pros1>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  2. Cairns J., Wright C., Cattan A. R., Hall A. G., Cantwell B. J., Harris A. L., Horne C. H. Immunohistochemical demonstration of glutathione S-transferases in primary human breast carcinomas. J Pathol. 1992 Jan;166(1):19–25. doi: 10.1002/path.1711660105. [DOI] [PubMed] [Google Scholar]
  3. Campbell J. A., Corrigall A. V., Guy A., Kirsch R. E. Immunohistologic localization of alpha, mu, and pi class glutathione S-transferases in human tissues. Cancer. 1991 Mar 15;67(6):1608–1613. doi: 10.1002/1097-0142(19910315)67:6<1608::aid-cncr2820670623>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  4. Canada A. T., Roberson K. M., Vessella R. L., Trump D. L., Robertson C. N., Fine R. L. Glutathione and glutathione S-transferase in benign and malignant prostate cell lines and prostate tissues. Biochem Pharmacol. 1996 Jan 12;51(1):87–90. doi: 10.1016/0006-2952(95)02157-4. [DOI] [PubMed] [Google Scholar]
  5. Cookson M. S., Reuter V. E., Linkov I., Fair W. R. Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue. J Urol. 1997 Feb;157(2):673–676. [PubMed] [Google Scholar]
  6. Di Ilio C., Aceto A., Bucciarelli T., Angelucci S., Felaco M., Grilli A., Federici G. Glutathione transferase isoenzymes from human prostate. Biochem J. 1990 Oct 15;271(2):481–485. doi: 10.1042/bj2710481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Green J. A., Robertson L. J., Clark A. H. Glutathione S-transferase expression in benign and malignant ovarian tumours. Br J Cancer. 1993 Aug;68(2):235–239. doi: 10.1038/bjc.1993.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hirata S., Odajima T., Kohama G., Ishigaki S., Niitsu Y. Significance of glutathione S-transferase-pi as a tumor marker in patients with oral cancer. Cancer. 1992 Nov 15;70(10):2381–2387. doi: 10.1002/1097-0142(19921115)70:10<2381::aid-cncr2820701002>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  9. Lee W. H., Morton R. A., Epstein J. I., Brooks J. D., Campbell P. A., Bova G. S., Hsieh W. S., Isaacs W. B., Nelson W. G. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11733–11737. doi: 10.1073/pnas.91.24.11733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mannervik B., Awasthi Y. C., Board P. G., Hayes J. D., Di Ilio C., Ketterer B., Listowsky I., Morgenstern R., Muramatsu M., Pearson W. R. Nomenclature for human glutathione transferases. Biochem J. 1992 Feb 15;282(Pt 1):305–306. doi: 10.1042/bj2820305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Montironi R., Valli M., Fabris G. Treatment of benign prostatic hyperplasia with 5-alpha-reductase inhibitor: morphological changes in patients who fail to respond. J Clin Pathol. 1996 Apr;49(4):324–328. doi: 10.1136/jcp.49.4.324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Moscow J. A., Fairchild C. R., Madden M. J., Ransom D. T., Wieand H. S., O'Brien E. E., Poplack D. G., Cossman J., Myers C. E., Cowan K. H. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res. 1989 Mar 15;49(6):1422–1428. [PubMed] [Google Scholar]
  13. Moskaluk C. A., Duray P. H., Cowan K. H., Linehan M., Merino M. J. Immunohistochemical expression of pi-class glutathione S-transferase is down-regulated in adenocarcinoma of the prostate. Cancer. 1997 Apr 15;79(8):1595–1599. doi: 10.1002/(sici)1097-0142(19970415)79:8<1595::aid-cncr23>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  14. Murray G. I., Taylor V. E., McKay J. A., Weaver R. J., Ewen S. W., Melvin W. T., Burke M. D. The immunohistochemical localization of drug-metabolizing enzymes in prostate cancer. J Pathol. 1995 Oct;177(2):147–152. doi: 10.1002/path.1711770208. [DOI] [PubMed] [Google Scholar]
  15. Niitsu Y., Takahashi Y., Saito T., Hirata Y., Arisato N., Maruyama H., Kohgo Y., Listowsky I. Serum glutathione-S-transferase-pi as a tumor marker for gastrointestinal malignancies. Cancer. 1989 Jan 15;63(2):317–323. doi: 10.1002/1097-0142(19890115)63:2<317::aid-cncr2820630219>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  16. Oude Ophuis M. B., van Lieshout E. M., Roelofs H. M., Peters W. H., Manni J. J. Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions. Cancer. 1998 Mar 1;82(5):936–943. [PubMed] [Google Scholar]
  17. Randall B. J., Angus B., Akiba R., Hall A., Cattan A. R., Proctor S. J., Jones R. A., Horne C. H. Glutathione S-transferase (placental) as a marker of transformation in the human cervix uteri: an immunohistochemical study. Br J Cancer. 1990 Oct;62(4):614–618. doi: 10.1038/bjc.1990.340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ripple M., Mulcahy R. T., Wilding G. Characteristics of the glutathione/glutathione-S-transferase detoxification system in melphalan resistant human prostate cancer cells. J Urol. 1993 Jul;150(1):209–214. doi: 10.1016/s0022-5347(17)35448-4. [DOI] [PubMed] [Google Scholar]
  19. Shiratori Y., Soma Y., Maruyama H., Sato S., Takano A., Sato K. Immunohistochemical detection of the placental form of glutathione S-transferase in dysplastic and neoplastic human uterine cervix lesions. Cancer Res. 1987 Dec 15;47(24 Pt 1):6806–6809. [PubMed] [Google Scholar]
  20. Stoner E. 5alpha-reductase inhibitors/finasteride. Prostate Suppl. 1996;6:82–87. [PubMed] [Google Scholar]
  21. Terrier P., Townsend A. J., Coindre J. M., Triche T. J., Cowan K. H. An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. Am J Pathol. 1990 Oct;137(4):845–853. [PMC free article] [PubMed] [Google Scholar]
  22. Tew K. D., Clapper M. L., Greenberg R. E., Weese J. L., Hoffman S. J., Smith T. M. Glutathione S-transferases in human prostate. Biochim Biophys Acta. 1987 Oct 8;926(1):8–15. doi: 10.1016/0304-4165(87)90177-2. [DOI] [PubMed] [Google Scholar]
  23. Thomas D. J., Birch P. J., Vickers J., Robinson M., Clifford S., Hall A., Neal D. E. Glutathione-S-transferase pi expression in transitional cell carcinoma of the bladder. Br J Urol. 1993 Nov;72(5 Pt 2):740–743. doi: 10.1111/j.1464-410x.1993.tb16259.x. [DOI] [PubMed] [Google Scholar]
  24. Toffoli G., Viel A., Tumiotto L., Giannini F., Volpe R., Quaia M., Boiocchi M. Expression of glutathione-S-transferase-pi in human tumours. Eur J Cancer. 1992;28A(8-9):1441–1446. doi: 10.1016/0959-8049(92)90540-i. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES